Drug intelligence / Profile preview

autologous bone marrow-derived mesenchymal stem cells (Sayed Bakry)

Development stage: Unknown
Lead developer: Al-Azhar University
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intraovarian

Overview

Autologous bone marrow-derived mesenchymal stem cells (BMSCs) is an investigational cell therapy developed by Sayed Bakry and researchers at Al-Azhar University for the treatment of premature ovarian failure (POF). The therapeutic process involves aspirating bone marrow from the patient's iliac crest, isolating and culturing the mesenchymal stem cells in autologous serum, and then suspending the purified cells in platelet-rich plasma (PRP). This preparation is then laparoscopically injected into the ovarian tissue and ligaments. The mechanism of action is based on the regenerative potential of stem cells to replenish damaged ovarian tissue and restore hormonal and reproductive function in women under 40.

Other names: Autologous Mesenchymal Stem Cells TransplantationBMSCsBone marrow-derived mesenchymal stem cells

Beyond the preview

Go deeper on autologous bone marrow-derived mesenchymal stem cells (Sayed Bakry).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived mesenchymal stem cells (Sayed Bakry).

Explore the full profile